Who owns Y Mabs Therapeutics Inc?
- Ticker: YMAB
- CUSIP Number: 984241109
Tip: Access positions for across all investors
Analyze quarterly positions in Y Mabs Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Y Mabs Therapeutics stock
Who bought or sold Y Mabs Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Paradigm Biocapital Advisors | 4.1M | $54M | 6% | Sep 2024 |
|
| BlackRock | 3.0M | $40M | 100% | Sep 2024 |
|
| BlackRock | 2.9M | $36M | 3% | Jun 2024 |
|
| Sofinnova Ventures | 2.2M | $29M | 0% | Sep 2024 |
|
| Vanguard Group | 2.0M | $24M | -5% | Jun 2024 |
|
| Cormorant Asset Management | 1.5M | $18M | 100% | Jun 2024 |
|
| Caligan Partners | 1.2M | $16M | 105% | Sep 2024 |
|
| Geode Capital Management | 814k | $11M | 6% | Sep 2024 |
|
| State Street Corporation | 805k | $9.7M | 7% | Jun 2024 |
|
| D. E. Shaw & Co | 788k | $10M | -15% | Sep 2024 |
|
| Pictet Asset Management Holding SA | 688k | $9.0M | -8% | Sep 2024 |
|
| Soleus Capital Management | 648k | $7.8M | 13% | Jun 2024 |
|
| Dimensional Fund Advisors | 478k | $6.3M | -1% | Sep 2024 |
|
| Northern Trust | 337k | $4.4M | 5% | Sep 2024 |
|
| Citadel Advisors | 295k | $3.9M | 5% | Sep 2024 |
|
| Charles Schwab Investment Management | 280k | $3.7M | 9% | Sep 2024 |
|
| Morgan Stanley | 203k | $2.5M | 8% | Jun 2024 |
|
| Jacobs Levy Equity Management | 150k | $2.0M | 0% | Sep 2024 |
|
| Goldman Sachs Group | 139k | $1.7M | -62% | Jun 2024 |
|
| Squarepoint Ops | 126k | $1.5M | 143% | Jun 2024 |
|
| Nuveen Asset Management | 113k | $1.4M | -58% | Jun 2024 |
|
| Rice Hall James & Associates | 109k | $1.4M | 21% | Sep 2024 |
|
| Acadian Asset Management | 106k | $1.4M | -67% | Sep 2024 |
|
| Two Sigma Advisers | 98k | $1.2M | -25% | Jun 2024 |
|
| Point72 Asset Management | 95k | $1.3M | -73% | Sep 2024 |
|
| Connor, Clark & Lunn Investment Management | 94k | $1.2M | -46% | Sep 2024 |
|
| Bank of New York Mellon | 92k | $1.2M | -24% | Sep 2024 |
|
| Bank of America Corporation | 80k | $1.0M | 78% | Sep 2024 |
|
| Bridgeway Capital Management | 76k | $918k | 16% | Jun 2024 |
|
| Barclays | 69k | $910k | 433% | Sep 2024 |
|
| Franklin Resources | 67k | $978k | 0% | Sep 2024 |
|
| Two Sigma Investments | 61k | $741k | -41% | Jun 2024 |
|
| Swiss National Bank | 60k | $793k | 0% | Sep 2024 |
|
| Alliancebernstein | 58k | $702k | -6% | Jun 2024 |
|
| Campbell & Co. Investment Adviser | 57k | $744k | -26% | Sep 2024 |
|
| Rhumbline Advisers | 52k | $688k | -4% | Sep 2024 |
|
| Federated Investors | 45k | $585k | 0% | Sep 2024 |
|
| Balyasny Asset Management | 44k | $531k | 100% | Jun 2024 |
|
| Sapient Capital | 44k | $575k | 0% | Sep 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 43k | $571k | 0% | Sep 2024 |
|
| Jane Street | 39k | $512k | -52% | Sep 2024 |
|
| Rafferty Asset Management | 35k | $461k | 100% | Sep 2024 |
|
| ALPS Advisors | 34k | $450k | 100% | Sep 2024 |
|
| Jpmorgan Chase & Co | 30k | $399k | 10% | Sep 2024 |
|
| California State Teachers Retirement System | 30k | $388k | -3% | Sep 2024 |
|
| Renaissance Technologies | 28k | $367k | -57% | Sep 2024 |
|
| Citigroup | 27k | $360k | 205% | Sep 2024 |
|
| AQR Capital Management | 27k | $358k | 24% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 26k | $347k | -2% | Sep 2024 |
|
| T. Rowe Price Associates | 23k | $297k | 1% | Sep 2024 |
|
| MetLife Investment Advisors | 22k | $291k | 0% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 21k | $279k | -6% | Sep 2024 |
|
| Principal Financial Group | 20k | $267k | 100% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 20k | $267k | 13% | Sep 2024 |
|
| EntryPoint Capital | 17k | $225k | 177% | Sep 2024 |
|
| Henderson Group | 16k | $197k | 100% | Jun 2024 |
|
| Marshall Wace | 16k | $204k | 100% | Sep 2024 |
|
| Florida State Board of Administration | 15k | $192k | 0% | Sep 2024 |
|
| Invesco | 15k | $191k | 2% | Sep 2024 |
|
| Manufacturers Life Insurance Company | 14k | $174k | -2% | Jun 2024 |
|
| Hrt Financial | 14k | $187k | 100% | Sep 2024 |
|
| SG Americas Securities | 14k | $178k | 100% | Sep 2024 |
|
| Exchange Traded Concepts | 13k | $169k | -11% | Sep 2024 |
|
| Ing Investment Management | 12k | $164k | -1% | Sep 2024 |
|
| Wells Fargo & Company | 11k | $149k | -4% | Sep 2024 |
|
| Royal Bank of Canada | 10k | $136k | 199% | Sep 2024 |
|
| Intech Investment Management | 10k | $134k | 100% | Sep 2024 |
|
| New York State Common Retirement Fund | 10k | $133k | -20% | Sep 2024 |
|
| China Universal Asset Management | 8.6k | $113k | 66% | Sep 2024 |
|
| Tower Research Capital | 6.9k | $83k | 104% | Jun 2024 |
|
| Lazard Asset Management | 4.2k | $55k | 100% | Sep 2024 |
|
| Summit Investment Advisors | 3.7k | $49k | 0% | Sep 2024 |
|
| Zurcher Kantonalbank | 3.3k | $44k | 100% | Sep 2024 |
|
| Great-West Life Assurance Company | 3.0k | $40k | 0% | Sep 2024 |
|
| Mirae Asset Global Investments | 1.6k | $21k | 23% | Sep 2024 |
|
| Amalgamated Bank | 1.2k | $16k | 0% | Sep 2024 |
|
| Quest Partners | 387.00 | $5.1k | 38600% | Sep 2024 |
|
| Russell Investments | 188.00 | $2.3k | 652% | Jun 2024 |
|
| Bessemer | 180.00 | $2.0k | 100% | Sep 2024 |
|
| NISA Investment Advisors | 164.00 | $2.2k | 209% | Sep 2024 |
|
| Daiwa Securities Group | 162.00 | $2.0k | 0% | Sep 2024 |
|
| CWM | 75.00 | $999.997500 | 12% | Sep 2024 |
|
| Eagle Bay Advisors | 50.00 | $658.000000 | 0% | Sep 2024 |
|
| GAMMA Investing | 40.00 | $526.000000 | 700% | Sep 2024 |
|
| Sterling Capital Management | 38.00 | $500.000200 | 100% | Sep 2024 |
|
| Lindbrook Capital | 32.00 | $420.998400 | 100% | Sep 2024 |
|
| Smartleaf Asset Management | 31.00 | $401.000500 | 100% | Sep 2024 |
|
| Rothschild Investment | 25.00 | $329.000000 | 100% | Sep 2024 |
|
| Parallel Advisors | 18.00 | $237.000600 | 100% | Sep 2024 |
|
| Us Bancorp | 17.00 | $224.000500 | 100% | Sep 2024 |
|
| Allspring Global Investments Holdings | 8.00 | $105.000000 | 100% | Sep 2024 |
|
| Capital Performance Advisors | 3.00 | $39.000000 | 100% | Sep 2024 |
|
| Farther Finance Advisors | 1.00 | $13.000000 | 0% | Sep 2024 |
|
Who sold out of Y Mabs Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 350k | $4.2M |
| Massachusetts Financial Services | Jun 2024 | 82k | $993k |
| Robeco Investment Management | Mar 2024 | 34k | $556k |
| XTX Topco | Jun 2024 | 25k | $297k |
| Sherbrooke Park Advisers | Jun 2024 | 24k | $286k |
| Verition Fund Management | Mar 2024 | 17k | $270k |
| Cubist Systematic Strategies | Jun 2024 | 6.6k | $80k |
| Quantbot Technologies | Mar 2024 | 4.5k | $74k |
| Aquatic Capital Management | Mar 2024 | 3.3k | $54k |
| Tucker Asset Management | Mar 2024 | 1.2k | $20k |
| HighMark Wealth Management | Jun 2024 | 220.00 | $2.7k |
| Signature | Jun 2024 | 64.00 | $772.998400 |
| Point72 | Jun 2024 | 53.00 | $637.001700 |